Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?

This publication has 26 references indexed in Scilit:

• Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
  New England Journal of Medicine, 1990
• Noninvasive axial and peripheral assessment of bone mineral content: A comparison between osteoporotic women and normal subjects
  Journal of Bone and Mineral Research, 1989
• Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis
  Bone, 1989
• Hip Fracture and the Use of Estrogens in Postmenopausal Women
  New England Journal of Medicine, 1987
• The influence of marrow on measurement of trabecular bone using computed tomography
  Bone, 1985
• BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY
  The Lancet, 1981
• Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
  New England Journal of Medicine, 1980
• Measurement of bone mineral content (BMC) of the lumbar spine, I. Theory and application of a new two-dimensional dual-photon attenuation method
  Scandinavian Journal of Clinical and Laboratory Investigation, 1980
• Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
  BMJ, 1980
• Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis
  Journal of Clinical Investigation, 1972